hsa-mir-4525: Hsa-mir-4525 is a microRNA (miRNA) that has been implicated in various biological processes and diseases. A variant deletion allele can lead to a decreased minimum free energy (MFE) for hsa-mir-4525, suggesting alterations in its stability and possibly its function [PMC3444488]. In the context of SARS-CoV-2 infection, hsa-mir-4525 is significantly upregulated, with a fold change (FC) greater than 100, indicating its potential role in the host response to the virus [PMC8890551]. The nucleotide insertion in the Omicron variant's Spike NTD provides a binding site for several miRNAs, including hsa-mir-4525, which may have implications for viral-host interactions [PMC9721271]. In small cell lung cancer (SCLC), hsa-mir-4525 is involved in regulatory networks with long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), which can neutralize its negative regulation on target genes such as GAA [PMC9291301]. Hsa-mir-4525 was identified as the most upregulated miRNA in a study on differential expression of miRNAs [PMC8097233], and it was also found to be upregulated in seminal plasma samples from non-azoospermic patients with positive testicular sperm extraction (TESE) results [PMC10051987]. Bioinformatics analysis and mechanistic studies have revealed that hsa-mir-4525 can form a competing endogenous RNA (ceRNA) network with lncRNA FOXP4–AS1 and FOXP4, suggesting complex regulatory interactions involving this miRNA [PMC10083663]. It has shown significant interactions with various lncRNAs based on validated CLIP experiments using DIANA tools [PMC9307901], further highlighting its role in post-transcriptional gene regulation.